Poor neighbourhood may predict severe skin lesions in discoid lupus erythematosus: JAMA

Published On 2024-07-31 16:15 GMT   |   Update On 2024-08-01 06:21 GMT
Advertisement

Researchers have found that socioeconomic and behavioral factors are of prime importance in the severity of discoid lupus erythematosus among the residents of Philadelphia. A recent study by Katharina S. Shaw, MD, and colleagues from the University of Pennsylvania added that people living in areas marked by poverty tended to have greater severity in manifestations of DLE; however, associations with racial identity were relatively weak after adjustment for socioeconomic factors. This study was published in JAMA Dermatology.

Advertisement

This study reviewed data on 154 adult DLE patients seen at the University of Pennsylvania's rheumatology-dermatology specialty clinic from 2007 to 2024. This was a cross-sectional analysis in which SES disadvantage was measured via the area deprivation index. ADI combines 17 neighborhood-level data points measuring education, employment, housing quality, and indicators of wealth into one index value from 1 to 10, with greater values indicating greater socioeconomic disadvantage.

Key Findings

• Among the 154 patients, 64% were Black, and 30% were white. At their first clinic visit, about one-quarter had moderate-to-severe disease activity, and three-quarters had moderate-to-severe damage.

• The mean ADI rating for Black patients was 6.8, compared to 2.7 for white patients.

• The odds of showing moderate to severe skin damage (CLASI-D ≥6) were roughly quadrupled among residents of census blocks with an ADI score greater than 5 compared with blocks rated at 5 or less (OR 3.90, 95% CI 1.27-12.69).

• Odds of high CLASI scores for disease activity (CLASI-A ≥10) were strongly associated with ADI values greater than 5 (OR 3.31, 95% CI 1.27-9.44).

• Initially, 87% of Black patients were characterized as having moderate-to-severe disease compared with 52% of white patients (P<0.001).

• After adjusting for ADI and other confounders, race was not significantly associated with higher CLASI-D severity (OR 2.78, 95% CI 0.95-8.44).

This study shows that SES and behavioral risk factors more strongly relate to poor health status in those with DLE than does racial identity. The bottom line for social policy implications is that already-recognized inequities at the structural level need to be addressed, and a more sophisticated approach—one which embeds a sense of socioeconomic context within which racial disparities are observed—taken toward understanding these issues.

In addition to socioeconomic factors, smoking status and SLE diagnosis were associated with higher disease activity and damage. Odds ratios for moderate-to-severe damage were 3.15 for current smoking and 3.63 for SLE; the odds ratios for moderate-to-severe disease activity were 2.20 and 1.97, respectively, where the latter did not reach statistical significance.

This suggests that smoking cessation programs should be available to all patients with DLE, more importantly in deprived areas. Second, neighborhood deprivation is potentially modifiable. Strategies that may influence this include increasing transportation, such as better access to health facilities, medical trust within the community, better education of patients, and medications should be afforded and easily accessible.

This study makes an explanation of the relationships between the socioeconomic factors and DLE severity, which is rather complex. Racial disparities in severity exist but these could be partially explained by socioeconomic deprivation. Further studies with larger sample sizes are required to further elucidate the association between the components of the ADI and DLE disease severity.

Reference:

Faden, D. F., Xie, L., Stone, C., Lopes Almeida Gomes, L., Le, T., Ezeh, N., Buckingham, W. R., Kind, A., Vleugels, R. A., Werth, V. P., Arkin, L., & Shaw, K. S. (2024). Area deprivation and disease severity in adult patients with discoid lupus erythematosus. JAMA Dermatology (Chicago, Ill.). https://doi.org/10.1001/jamadermatol.2024.2355

Tags:    
Article Source : JAMA Dermatology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News